The next 10 years in personalized medicine in cardiology.
Publication
, Journal Article
Tantry, US; Gurbel, PA
Published in: Expert Rev Cardiovasc Ther
August 2013
Duke Scholars
Published In
Expert Rev Cardiovasc Ther
DOI
EISSN
1744-8344
Publication Date
August 2013
Volume
11
Issue
8
Start / End Page
933 / 935
Location
England
Related Subject Headings
- Precision Medicine
- Practice Guidelines as Topic
- Hypolipidemic Agents
- Humans
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Antihypertensive Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., & Gurbel, P. A. (2013). The next 10 years in personalized medicine in cardiology. Expert Rev Cardiovasc Ther, 11(8), 933–935. https://doi.org/10.1586/14779072.2013.814823
Tantry, Udaya S., and Paul A. Gurbel. “The next 10 years in personalized medicine in cardiology.” Expert Rev Cardiovasc Ther 11, no. 8 (August 2013): 933–35. https://doi.org/10.1586/14779072.2013.814823.
Tantry US, Gurbel PA. The next 10 years in personalized medicine in cardiology. Expert Rev Cardiovasc Ther. 2013 Aug;11(8):933–5.
Tantry, Udaya S., and Paul A. Gurbel. “The next 10 years in personalized medicine in cardiology.” Expert Rev Cardiovasc Ther, vol. 11, no. 8, Aug. 2013, pp. 933–35. Pubmed, doi:10.1586/14779072.2013.814823.
Tantry US, Gurbel PA. The next 10 years in personalized medicine in cardiology. Expert Rev Cardiovasc Ther. 2013 Aug;11(8):933–935.
Published In
Expert Rev Cardiovasc Ther
DOI
EISSN
1744-8344
Publication Date
August 2013
Volume
11
Issue
8
Start / End Page
933 / 935
Location
England
Related Subject Headings
- Precision Medicine
- Practice Guidelines as Topic
- Hypolipidemic Agents
- Humans
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Antihypertensive Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services